{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:20:18Z","timestamp":1787026818465,"version":"build-2736575974"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T00:00:00Z","timestamp":1616544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011645","name":"Kaohsiung Medical University Chung-Ho Memorial Hospital","doi-asserted-by":"publisher","award":["KMUH-108-8R47"],"award-info":[{"award-number":["KMUH-108-8R47"]}],"id":[{"id":"10.13039\/501100011645","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>The coronavirus disease 2019 (COVID-19) pandemic has prompted a rapid and unprecedented reorganization of medical institutions, affecting clinical care for patients with chronic neurological diseases. Although there is no evidence that patients with neuromuscular disorders (NMD) confer a higher infection risk of COVID-19, NMD and its associated therapies may affect the patient's ability to cope with infection or its systemic effects. Moreover, there is a concern that patients with chronic NMD may be at increased risk of manifesting severe symptoms of COVID-19. In particular, as respiratory compromises account for the major cause of mortality and morbidity in NMD patients, newly emerging data also show that the risk of exacerbation caused by COVID-19 accumulates in this particular patient group. For example, patients with motor neuron disease and dystrophinopathies often have ventilatory muscle weakness or cardiomyopathy, which may increase the risk of severe COVID-19 infection. Thus, the COVID-19 pandemic may severely affect NMD patients. Several neurological associations and neuromuscular networks have recently guided the impact of COVID-19 on patients with NMD, especially in managing cardiopulmonary involvements. It is recommended that patients with moderate- to high-risk NMD be sophisticatedly monitored to reduce the risk of rapid decline in cardiopulmonary function or potential deterioration of the underlying NMD. However, limited neuromuscular-specific recommendations for NMD patients who contract COVID-19 and outcome data are lacking. There is an urgent need to properly modify the respiratory care method for NMD patients, especially during the COVID-19 pandemic. Conclusively, COVID-19 is a rapidly evolving field, and the practical guidelines for the management of NMD patients are frequently revised. There must be a close collaboration in a multidisciplinary care team that should support their hospital to define a standardized care method for NMD patients during the COVID pandemic. This article reviews evidence-based practical guidelines regarding care delivery, modification, and education, highlighting the need for team-based and interspecialty collaboration.<\/jats:p>","DOI":"10.3389\/fneur.2021.607790","type":"journal-article","created":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T01:29:47Z","timestamp":1616549387000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Care for Patients With Neuromuscular Disorders in the COVID-19 Pandemic Era"],"prefix":"10.3389","volume":"12","author":[{"given":"Yung-Hao","family":"Tseng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai-Heng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,24]]},"reference":[{"key":"B1","unstructured":"Coronavirus Disease (COVID-19) Weekly Epidemiological Update"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1056\/NEJMc2005073","article-title":"SARS-CoV-2 infection in children","volume":"382","author":"Lu","year":"2020","journal-title":"N Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"9032","DOI":"10.4081\/ejtm.2019.9032","article-title":"Neuromuscular diseases and Covid-19: Advices from scientific societies and early observations in Italy","volume":"30","author":"Angelini","year":"2020","journal-title":"Eur J Transl Myol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"664","DOI":"10.3389\/fneur.2020.00664","article-title":"Chronic neurology in COVID-19 era: clinical considerations and recommendations from the REPROGRAM Consortium","volume":"11","author":"Bhaskar","year":"2020","journal-title":"Front Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1212\/WNL.0000000000009566","article-title":"COVID-19 and neuromuscular disorders","volume":"94","author":"Guidon","year":"2020","journal-title":"Neurology."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-10149-2","article-title":"Management of patients with neuromuscular disorders at the time of the SARS-CoV-2 pandemic","author":"Costamagna","year":"2020","journal-title":"J Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/mus.26115","article-title":"Telehealth applications for outpatients with neuromuscular or musculoskeletal disorders","volume":"58","author":"Howard","year":"2018","journal-title":"Muscle Nerve."},{"key":"B8","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.neurol.2020.04.004","article-title":"Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network","volume":"176","author":"Sole","year":"2020","journal-title":"Rev Neurol."},{"key":"B9","unstructured":"150Covid-19 and People With Neuromuscular Disorders: World Muscle Society Position and Advice"},{"key":"B10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/mus.26902","article-title":"The care of patients with Duchenne, Becker, and other muscular dystrophies in the COVID-19 pandemic","volume":"62","author":"Veerapandiyan","year":"2020","journal-title":"Muscle Nerve."},{"key":"B11","doi-asserted-by":"publisher","first-page":"116803","DOI":"10.1016\/j.jns.2020.116803","article-title":"Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic","volume":"412","author":"International","year":"2020","journal-title":"J Neurol Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of COVID-19: immunity, inflammation and intervention","volume":"20","author":"Tay","year":"2020","journal-title":"Nat Rev Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1001\/jama.2020.16747","article-title":"Corticosteroids in COVID-19 ARDS: evidence and hope during the pandemic","volume":"324","author":"Prescott","year":"2020","journal-title":"JAMA."},{"key":"B14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/mus.26447","article-title":"Long-term safety and efficacy of eculizumab in generalized myasthenia gravis","volume":"60","author":"Muppidi","year":"2019","journal-title":"Muscle Nerve."},{"key":"B15","doi-asserted-by":"publisher","first-page":"4040","DOI":"10.26355\/eurrev_202004_20875","article-title":"Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience","volume":"24","author":"Diurno","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1016\/S0140-6736(16)31408-8","article-title":"Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study","volume":"388","author":"Finkel","year":"2016","journal-title":"Lancet."},{"key":"B17","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/mus.26903","article-title":"Spinal muscular atrophy care in the COVID-19 pandemic era","volume":"62","author":"Veerapandiyan","year":"2020","journal-title":"Muscle Nerve."},{"key":"B18","unstructured":"FDA Approves Oral Treatment for Spinal Muscular Atrophy"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1007\/s00415-018-9065-7","article-title":"36-Months follow-up assessment after cessation and resuming of enzyme replacement therapy in late onset Pompe disease: data from the Swiss Pompe Registry","volume":"265","author":"Scheidegger","year":"2018","journal-title":"J Neurol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1682\/JRRD.2014.10.0239","article-title":"Effects of physical therapy delivery via home video telerehabilitation on functional and health-related quality of life outcomes","volume":"52","author":"Levy","year":"2015","journal-title":"J Rehabil Res Dev."},{"key":"B21","doi-asserted-by":"publisher","first-page":"556720","DOI":"10.3389\/fpubh.2020.556720","article-title":"Telemedicine Across the Globe-Position Paper From the COVID-19 Pandemic Health System Resilience PROGRAM (REPROGRAM) International Consortium (Part 1)","volume":"8","author":"Bhaskar","year":"2020","journal-title":"Front Public Health."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1753466620953789","DOI":"10.1177\/1753466620953789","article-title":"Respiratory management for patients with neuromuscular disorders during the COVID-19 pandemic","volume":"14","author":"Chen","year":"2020","journal-title":"Ther Adv Respir Dis."},{"key":"B23","unstructured":"Clinical Management of Severe Acute Respiratory Infection When Novel Coronavirus (2019-nCoV) Infection Is Suspected: Interim Guidance"},{"key":"B24","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S2213-2600(20)30304-0","article-title":"COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted?","volume":"8","author":"Fan","year":"2020","journal-title":"Lancet Respir Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s00134-020-06033-2","article-title":"COVID-19 pneumonia: different respiratory treatments for different phenotypes?","volume":"46","author":"Gattinoni","year":"2020","journal-title":"Intensive Care Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1753466620951032","DOI":"10.1177\/1753466620951032","article-title":"Helmet CPAP: how an unfamiliar respiratory tool is moving into treatment options during COVID-19 in the US","volume":"14","author":"Armirfarzan","year":"2020","journal-title":"Ther Adv Respir Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"389","DOI":"10.7326\/M13-2486","article-title":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection","volume":"160","author":"Arabi","year":"2014","journal-title":"Ann Intern Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1753466619875928","DOI":"10.1177\/1753466619875928","article-title":"Combined noninvasive ventilation and mechanical insufflator-exsufflator for acute respiratory failure in patients with neuromuscular disease: effectiveness and outcome predictors","volume":"13","author":"Chen","year":"2019","journal-title":"Ther Adv Respir Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"i1","DOI":"10.1136\/thoraxjnl-2012-201964","article-title":"British Thoracic Society guideline for respiratory management of children with neuromuscular weakness","volume":"67","author":"Hull","year":"2012","journal-title":"Thorax."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.3389\/fimmu.2020.01648","article-title":"Cytokine storm in COVID-19-immunopathological mechanisms, clinical considerations, and therapeutic approaches: The REPROGRAM Consortium Position Paper","volume":"11","author":"Bhaskar","year":"2020","journal-title":"Front Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1016\/S2213-2600(20)30110-7","article-title":"Respiratory support for patients with COVID-19 infection","volume":"8","author":"Namendys-Silva","year":"2020","journal-title":"Lancet Respir Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1378\/chest.14-1934","article-title":"Exhaled air dispersion during noninvasive ventilation via helmets and a total facemask","volume":"147","author":"Hui","year":"2015","journal-title":"Chest."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-21269\/v1","article-title":"Noninvasive ventilation masks with viral filters to protect health care workers from SARS-CoV-2 \/ Coronavirus infections","author":"Dellweg","year":"2020","journal-title":"Res Square."},{"key":"B34","first-page":"419","article-title":"Recommendations for anesthesia and perioperative management of patients with neuromuscular disorders","volume":"79","author":"Racca","year":"2013","journal-title":"Minerva Anestesiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/ACO.0000000000000466","article-title":"Anesthetic consideration for neuromuscular diseases","volume":"30","author":"Katz","year":"2017","journal-title":"Curr Opin Anaesthesiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3390\/children5090126","article-title":"Multidisciplinary perioperative care for children with neuromuscular disorders","volume":"5","author":"Kynes","year":"2018","journal-title":"Children."},{"key":"B37","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.nmd.2004.10.017","article-title":"Complications of anaesthesia in neuromuscular disorders","volume":"15","author":"Klingler","year":"2005","journal-title":"Neuromuscul Disord."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1001\/jama.2020.3633","article-title":"Care for Critically Ill Patients With COVID-19","volume":"323","author":"Murthy","year":"2020","journal-title":"JAMA."},{"key":"B39","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0300-9572(01)00362-8","article-title":"Cardiac arrest during surgery and ventilation in the prone position: a case report and systematic review","volume":"50","author":"Brown","year":"2001","journal-title":"Resuscitation."},{"key":"B40","doi-asserted-by":"publisher","first-page":"287","DOI":"10.7326\/M20-2496","article-title":"Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19: A Living Systematic Review","volume":"173","author":"Hernandez","year":"2020","journal-title":"Ann Intern Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1056\/NEJMe2020388","article-title":"Hydroxychloroquine for the prevention of Covid-19 - searching for evidence","volume":"383","author":"Cohen","year":"2020","journal-title":"N Engl J Med."},{"key":"B42","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1056\/NEJMoa2019014","article-title":"Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19","volume":"383","author":"Cavalcanti","year":"2020","journal-title":"N Engl J Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"105949","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","volume":"56","author":"Gautret","year":"2020","journal-title":"Int J Antimicrob Agents."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e208857","DOI":"10.1001\/jamanetworkopen.2020.8857","article-title":"Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a randomized clinical trial","volume":"3","author":"Borba","year":"2020","journal-title":"JAMA Netw Open."},{"key":"B45","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3988\/jcn.2013.9.3.186","article-title":"Prolonged corrected QT interval in patients with myotonic dystrophy type 1","volume":"9","author":"Park","year":"2013","journal-title":"J Clin Neurol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.cjca.2020.04.003","article-title":"Guidance on minimizing risk of drug-induced ventricular arrhythmia during treatment of COVID-19: A Statement from the Canadian Heart Rhythm Society","volume":"36","author":"Sapp","year":"2020","journal-title":"Can J Cardiol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/mus.26689","article-title":"Factors associated with acute exacerbations of myasthenia gravis","volume":"60","author":"Gummi","year":"2019","journal-title":"Muscle Nerve."},{"key":"B48","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1111\/neup.12520","article-title":"Hydroxychloroquine-induced autophagic vacuolar myopathy with mitochondrial abnormalities","volume":"38","author":"Khosa","year":"2018","journal-title":"Neuropathology."},{"key":"B49","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3851\/IMP1747","article-title":"Rhabdomyolysis in an HIV-infected patient with impaired renal function concomitantly treated with rosuvastatin and lopinavir\/ritonavir","volume":"16","author":"de Kanter","year":"2011","journal-title":"Antivir Ther."},{"key":"B50","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet."},{"key":"B51","doi-asserted-by":"publisher","first-page":"E57","DOI":"10.1002\/mus.27003","article-title":"COVID-19-associated myositis with severe proximal and bulbar weakness","volume":"62","author":"Zhang","year":"2020","journal-title":"Muscle Nerve."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.607790\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T01:29:52Z","timestamp":1616549392000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.607790\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,24]]},"references-count":51,"alternative-id":["10.3389\/fneur.2021.607790"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.607790","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,24]]},"article-number":"607790"}}